Peptide record

TPDB92223

TAT Antibacterial Anticancer Antiviral Cell-penetrating Peptides modified_plain modified
10 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB92223
TAT
Antibacterial Anticancer Antiviral Cell-penetrating Peptides
Anti-infective peptides Cancer-related peptides Delivery and barrier-penetrating peptides
dbAMP Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF AI4AVP dbAMP 3.0 DRAVP 2.0 CellPPD CPPsite3.0
modified_plain
Yes
A 10-aa modified multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide sequence curated from dbAMP, Peptipedia, AntiCP 2.0, and other sources, with an available 3D structural model.
C-terminal: Amidation N-terminal: Conjugated with FITC
Sequence
GRKKRRQRRR-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
10 reviewed residue count
Amidation Activity
L Activity
Cationic Activity
Linear Activity
Conjugated with FITC Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

B16F10, HeLa, 4T1 Cells , Fresh Rabbit Red Blood Cells (Rbcs) , Fresh Tumor Tissues

Assay & Model

4T1 tumor-bearing BALB/c mice
4T1 tumor-bearing BALB/c mice

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Non-natural residues Linear L Cationic
Protein derived
FITC dye
In-vitro, in-vivo and ex vivo